Abstract
Tumor secreted extracellular vesicles (EVs) are potent intercellular signaling platforms. They are responsible for the accommodation of the premetastatic niche (PMN) to support cancer cell engraftment and metastatic growth. However, complex cancer cell composition within the tumor increases also the heterogeneity among cancer secreted EVs subsets, a functional diversity that has been poorly explored. This phenomenon is particularly relevant in highly plastic and heterogenous triple-negative breast cancer (TNBC), in which a significant representation of malignant cancer stem cells (CSCs) is displayed. Herein, we selectively isolated and characterized EVs from CSC or differentiated cancer cells (DCC; EVsCSC and EVsDCC, respectively) from the MDA-MB-231 TNBC cell line. Our results showed that EVsCSC and EVsDCC contain distinct bioactive cargos and therefore elicit a differential effect on stromal cells in the TME. Specifically, EVsDCC activated secretory cancer associated fibroblasts (CAFs), triggering IL-6/IL-8 signaling and sustaining CSC phenotype maintenance. Complementarily, EVsCSC promoted the activation of α-SMA+ myofibroblastic CAFs subpopulations and increased the endothelial remodeling, enhancing the invasive potential of TNBC cells in vitro and in vivo. In addition, solely the EVsCSC mediated signaling prompted the transformation of healthy lungs into receptive niches able to support metastatic growth of breast cancer cells.
Original language | English |
---|---|
Pages (from-to) | 2153-2165 |
Number of pages | 13 |
Journal | International Journal of Cancer |
Volume | 152 |
Issue number | 10 |
DOIs | |
Publication status | Published - 15 May 2023 |
Bibliographical note
Funding Information:Our study was supported by ISCIII PI20/01474 (co‐founded by Fondo Europeo de Desarrollo Regional [FEDER]) granted to Simó Schwartz Jr and Petra Gener, the 2017‐SGR‐638 and ‐1427 form the Generalitat de Catalunya to Simó Schwartz Jr and Anna Rose, respectively, and PENTRI‐2 from CIBER‐BBN granted to Ibane Abasolo. Anna Labernadie is recipient of Obra Social “La Caixa” Junior Leader Postdoctoral Fellowship, (LCF/BQ/PR18/11640001). Joaquin Seras‐Franzoso was awarded with an Asociación Española Contra el Cancer (AECC), (AIO14142112SERA) post‐doctoral fellowship.
Funding
Our study was supported by ISCIII PI20/01474 (co‐founded by Fondo Europeo de Desarrollo Regional [FEDER]) granted to Simó Schwartz Jr and Petra Gener, the 2017‐SGR‐638 and ‐1427 form the Generalitat de Catalunya to Simó Schwartz Jr and Anna Rose, respectively, and PENTRI‐2 from CIBER‐BBN granted to Ibane Abasolo. Anna Labernadie is recipient of Obra Social “La Caixa” Junior Leader Postdoctoral Fellowship, (LCF/BQ/PR18/11640001). Joaquin Seras‐Franzoso was awarded with an Asociación Española Contra el Cancer (AECC), (AIO14142112SERA) post‐doctoral fellowship.
Funders | Funder number |
---|---|
International Centre for Theoretical Sciences | |
Generalitat de Catalunya | PENTRI‐2, LCF/BQ/PR18/11640001 |
Federación Española de Enfermedades Raras | |
Instituto de Salud Carlos III | PI20/01474 |
European Regional Development Fund |
Keywords
- cancer cell plasticity
- extracellular vesicles
- premetastatic niche
- triple-negative breast cancer
- tumor microenvironment